The antioxidative property of melatonin against brain ischemia

References

• Sauer D, Nuglisch J, Rossberg C, et al. Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow. Neurosci Lett. 1988;91(3):327–332.
   PubMed Web of Science ®Google Scholar
• Nuglisch J, Karkoutly C, Mennel HD, et al. Protective effect of nimodipine against ischemic neuronal damage in rat hippocampus without changing postischemic cerebral blood flow. J Cereb Blood Flow Metab. 1990;10(5):654–659.
   PubMed Web of Science ®Google Scholar
• Prehn JH, Backhauss C, Karkoutly C, et al. Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur J Pharmacol. 1991;203(2):213–222.
   PubMed Web of Science ®Google Scholar
• Sauer D, Rischke R, Beck T, et al. Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sci. 1988;43(21):1733–1739.
   PubMed Web of Science ®Google Scholar
• Prehn JH, Karkoutly C, Nuglisch J, et al. Dihydrolipoate reduces neuronal injury after cerebral ischemia. J Cereb Blood Flow Metab. 1992;12(1):78–87.
   PubMed Web of Science ®Google Scholar
• Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36(4):557–565.
   PubMed Web of Science ®Google Scholar
• Buchan A. Advances in cerebral ischemia: experimental approaches. Neurol Clin. 1992;10(1):49–61.
   PubMed Web of Science ®Google Scholar
• Hossmann KA. Disturbances of cerebral protein synthesis and ischemic cell death. Prog Brain Res. 1993;96:161–177.
   PubMed Web of Science ®Google Scholar
• Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 1996;6(5):667–672.
   PubMed Web of Science ®Google Scholar
• Lee J-M, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399(6738):A7–A14.
   PubMed Web of Science ®Google Scholar
• Paschen W. Role of calcium in neuronal cell injury: which subcellular compartment is involved? Brain Res Bull. 2000;53(4):409–413.
   PubMed Web of Science ®Google Scholar
• Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21(1):2–14.
   PubMed Web of Science ®Google Scholar
• Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol. 2001;14(1):89–94.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Dean RL 3rd, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp Neurol. 2002;173(1):168–181.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol. 1998;56(3):359–384.
   PubMed Web of Science ®Google Scholar
• Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 1994;78(6):927–930.
   PubMed Web of Science ®Google Scholar
• Forstermann U, Boissel JP, Kleinert H. Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12(10):773–790.
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer RM, Higgs EA. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol. 1989;38(11):1709–1715.
   PubMed Web of Science ®Google Scholar
• Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14(2):60–67.
   PubMed Web of Science ®Google Scholar
• Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest. 1997;100(10):2424–2429.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan D-X, Manchester LC, et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys. 2001;34(2):237–256.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol. 2001;426(1–2):1–10.
   PubMed Web of Science ®Google Scholar
• Natarajan M, Reiter RJ, Meltz ML, et al. Effect of melatonin on cell growth, metabolic activity, and cell cycle distribution. J Pineal Res. 2001;31(3):228–233.
   PubMed Web of Science ®Google Scholar
• Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev. 2002;39(1):55–73.
   PubMedGoogle Scholar
• Cheung RT, Pei Z, Feng ZH, et al. Cyclooxygenase-1 gene knockout does not alter middle cerebral artery occlusion in a mouse stroke model. Neurosci Lett. 2002;330(1):57–60.
   PubMed Web of Science ®Google Scholar
• Oliver CN, Starke-Reed PE, Stadtman ER, et al. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A. 1990;87(13):5144–5147.
   PubMed Web of Science ®Google Scholar
• Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol. 1992;32:S22–S27.
   PubMed Web of Science ®Google Scholar
• Hall NC, Carney JM, Cheng M, et al. Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-α-phenylnitrone and difluoromethylornithine. Neuroscience. 1995;69(2):591–600.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cordaro M, Cuzzocrea S. Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. Pharmacol Res. 2014;86:26–31.
   PubMed Web of Science ®Google Scholar
• Allegra M, Reiter RJ, Tan DX, et al. The chemistry of melatonin’s interaction with reactive species. J Pineal Res. 2003;34(1):1–10.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Acuña-Castroviejo D, Tan DX, et al. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci. 2001;939:200–215.
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002;2(2):181–197.
   PubMedGoogle Scholar
• Reiter RJ, Tan D-X, Osuna C, et al. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci. 2000;7(6):444–458.
   PubMed Web of Science ®Google Scholar
• Acuña-Castroviejo D, Martín M, Macías M, et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res. 2001;30(2):65–74.
   PubMed Web of Science ®Google Scholar
• Acarin L, González B, Castellano B. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci. 2000;12(10):3505–3520.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, BaHammam AS, Brown GM, et al. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res. 2013;23(3):267–300.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan D-X, Manchester LC, et al. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol. 2007;58 Suppl 6:5–22.
   PubMed Web of Science ®Google Scholar
• Esposito E, Genovese T, Caminiti R, et al. Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury. J Pineal Res. 2009;46(1):79–86.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 2005;27(2):101–110.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335–353.
   PubMed Web of Science ®Google Scholar
• Slominski A, Fischer TW, Zmijewski MA, et al. On the role of melatonin in skin physiology and pathology. Endocrine. 2005;27(2):137–148.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Hudson RL, Sumaya IC, et al. Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse. J Pineal Res. 2005;39(2):113–120.
   PubMed Web of Science ®Google Scholar
• Barrenetxe J, Delagrange P, Martínez JA. Physiological and metabolic functions of melatonin. J Physiol Biochem. 2004;60(1):61–72.
   PubMed Web of Science ®Google Scholar
• Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005;27(2):189–200.
   PubMed Web of Science ®Google Scholar
• Smirnov AN. Nuclear melatonin receptors. Biochem Biokhim. 2001;66(1):19–26.
   PubMed Web of Science ®Google Scholar
• Calvo JR, González-Yanes C, Maldonado MD. The role of melatonin in the cells of the innate immunity: a review. J Pineal Res. 2013;55(2):103–120.
   PubMed Web of Science ®Google Scholar
• Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol. 2007;58 Suppl 6:115–124.
   PubMed Web of Science ®Google Scholar
• Paradies G, Petrosillo G, Paradies V, et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res. 2010;48(4):297–310.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol. 2009;44(4):175–200.
   PubMed Web of Science ®Google Scholar
• León J, Acuña-Castroviejo D, Escames G, et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res. 2005;38(1):1–9.
   PubMed Web of Science ®Google Scholar
• Martín M, Macías M, Escames G, et al. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J. 2000;14(12):1677–1679.
   PubMed Web of Science ®Google Scholar
• Akbulut KG, Gonul B, Akbulut H. The role of melatonin on gastric mucosal cell proliferation and telomerase activity in ageing. J Pineal Res. 2009;47(4):308–312.
   PubMed Web of Science ®Google Scholar
• Ganguly K, Swarnakar S. Induction of matrix metalloproteinase-9 and −3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res. 2009;47(1):43–55.
   PubMed Web of Science ®Google Scholar
• Tajes Orduna M, Pelegri Gabalda C, Vilaplana Hortensi J, et al. An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis. J Pineal Res. 2009;46(3):262–267.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Sainz RM, et al. Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res. 2005;39(2):185–194.
   PubMed Web of Science ®Google Scholar
• Milczarek R, Hallmann A, Sokolowska E, et al. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res. 2010;49(2):149–155.
   PubMed Web of Science ®Google Scholar
• Sainz RM, Mayo JC, Rodriguez C, et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. CMLS. 2003;60(7):1407–1426.
   PubMed Web of Science ®Google Scholar
• Martin M, Macias M, Escames G, et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res. 2000;28(4):242–248.
   PubMed Web of Science ®Google Scholar
• Huang CC, Lai CJ, Tsai MH, et al. Effects of melatonin on the nitric oxide system and protein nitration in the hypobaric hypoxic rat hippocampus. BMC Neurosci. 2015;16:61.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Thiemermann C, Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem. 2004;11(9):1147–1162.
   PubMed Web of Science ®Google Scholar
• Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res. 2007;42(4):386–393.
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36(1):1–9.
   PubMed Web of Science ®Google Scholar
• Muxel SM, Pires-Lapa MA, Monteiro AW, et al. NF-kappaB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One. 2012;7(12):e52010.
   PubMed Web of Science ®Google Scholar
• Liu Y-J, Zhuang J, Zhu H-Y, et al. Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm. J Pineal Res. 2007;43(3):232–238.
   PubMed Web of Science ®Google Scholar
• Liu Y-J, Meng F-T, Wu L, et al. Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells. Neuro Endocrinol Lett. 2013;34(3):236–240.
   PubMed Web of Science ®Google Scholar
• Liu Y-J, Meng F-T, Wang -L-L, et al. Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells. J Pineal Res. 2012;52(4):397–402.
   PubMed Web of Science ®Google Scholar
• Anderson G, Maes M. Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders. CNS Neurol Disord Drug Targets. 2014;13(5):817–827.
   PubMed Web of Science ®Google Scholar
• Jang SW, Liu X, Pradoldej S, et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci U S A. 2010;107(8):3876–3881.
   PubMed Web of Science ®Google Scholar
• Tan D-X, Manchester LC, Sanchez-Barcelo E, et al. Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system. Curr Neuropharmacol. 2010;8(3):162–167.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan D-X, Leon J, et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood). 2005;230(2):104–117.
   PubMed Web of Science ®Google Scholar
• Lee S-H, Chun W, Kong P-J, et al. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J Pineal Res. 2006;40(1):79–85.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995;9(7):526–533.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol. 2010;8(3):228–242.
   PubMed Web of Science ®Google Scholar
• Paredes SD, Rancan L, Kireev R, et al. Melatonin counteracts at a transcriptional level the inflammatory and apoptotic response secondary to ischemic brain injury induced by middle cerebral artery blockade in aging rats. Biores Open Access. 2015;4(1):407–416.
   PubMed Web of Science ®Google Scholar
• Lee E-J, Lee M-Y, Chen H-Y, et al. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia. J Pineal Res. 2005;38(1):42–52.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan D-X, Sainz RM, et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 2002;54(10):1299–1321.
   PubMed Web of Science ®Google Scholar
• Genovese T, Mazzon E, Crisafulli C, et al. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res. 2007;43(2):140–153.
   PubMed Web of Science ®Google Scholar
• Lee E-J, Wu T-S, Lee M-Y, et al. Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats. J Pineal Res. 2004;36(1):33–42.
   PubMed Web of Science ®Google Scholar
• Yang Y, Jiang S, Dong Y, et al. Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. J Pineal Res. 2015;58(1):61–70.
   PubMed Web of Science ®Google Scholar
• Wang X, Figueroa BE, Stavrovskaya IG, et al. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury. Stroke. 2009;40(5):1877–1885.
   PubMed Web of Science ®Google Scholar
• Balduini W, Carloni S, Perrone S, et al. The use of melatonin in hypoxic-ischemic brain damage: an experimental study. J Matern Fetal Neonatal Med. 2012;25 Suppl 1:119–124.
   PubMed Web of Science ®Google Scholar
• Kilic U, Kilic E, Reiter RJ, et al. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res. 2005;38(1):67–71.
   PubMed Web of Science ®Google Scholar
• Kilic E, Kilic U, Reiter RJ, et al. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt. J Pineal Res. 2005;39(2):151–155.
   PubMed Web of Science ®Google Scholar
• Manev H, Uz T, Kharlamov A, et al. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J. 1996;10(13):1546–1551.
   PubMed Web of Science ®Google Scholar
• Joo JY, Uz T, Manev H. Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restor Neurol Neurosci. 1998;13(3–4):185–191.
   PubMed Web of Science ®Google Scholar
• Pei Z, Ho HT, Cheung RT. Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat. Neurosci Lett. 2002;318(3):141–144.
   PubMed Web of Science ®Google Scholar
• Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke. 2003;34(3):770–775.
   PubMed Web of Science ®Google Scholar
• Chen TY, Lee MY, Chen HY, et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res. 2006;40(3):242–250.
   PubMed Web of Science ®Google Scholar
• Chen HY, Chen TY, Lee MY, et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res. 2006;41(2):175–182.
   PubMed Web of Science ®Google Scholar